KLTO
KLTO
NASDAQ · Biotechnology

Klotho Neurosciences Inc

$0.24
+0.02 (+8.84%)
As of Feb 8, 2:26 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 2.95M 2.89M 2.41M
Net Income -877,894 -779,690 -617,534
EPS
Profit Margin -29.8% -27.0% -25.7%
Rev Growth +6.0% +2.0% +0.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 7.78M 8.04M 6.27M
Total Equity 11.74M 12.17M 13.18M
D/E Ratio 0.66 0.66 0.48
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -957,867 -819,475 -798,278
Free Cash Flow -748,445 -747,364 -598,338